|
Cardiovascular Risks, Bleeding Risks, and Clinical Events from 3 Phase III Trials of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis |
|
|
|
Titel: |
Cardiovascular Risks, Bleeding Risks, and Clinical Events from 3 Phase III Trials of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis |
Auteur: |
Glassberg, Marilyn K. Nathan, Steven D. Lin, Chin-Yu Morgenthien, Elizabeth A. Stauffer, John L. Chou, Willis Noble, Paul W. |
Verschenen in: |
Advances in therapy |
Paginering: |
Jaargang 36 (2019) nr. 10 pagina's 2910-2926 |
Jaar: |
2019 |
Inhoud: |
|
Uitgever: |
Springer Healthcare, Cheshire |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|